This chapter delves into the potential impact of geroprotective drugs like rapamycin, metformin, NAD, and resveratrol on aging, discussing their origins, studies on their efficacy, and current perceptions. It highlights the need for more research to conclusively prove their benefits in humans and explores the complexities of prescribing these drugs responsibly for longevity. The episode also covers the decline of NAD with age, NAD precursors like NR and NMN in disease treatment, and skepticism around the effectiveness of resveratrol despite its historical significance.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode